Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin

per Ramakrishnan, Melarkode S, Eswaraiah, Anand, Crombet, Tania, Piedra, Patricia, Saurez, Giselle, Iyer, Harish, Arvind, AS
Publicat 2009

Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma

per Osorio, Marta, Gracia, Elias, Reigosa, Edmundo, Hernandez, Julio, de la Torre, Ana, Saurez, Giselle, Perez, Kirenia, Viada, Carmen, Cepeda, Meylán, Carr, Adriana, Ávila, Yisel, Rodríguez, Migdalia, Fernandez, Luis E
Publicat 2012

Treatment of children with high grade glioma with nimotuzumab: A 5-y institutional experience

per Cabanas, Ricardo, Saurez, Giselle, Rios, Martha, Alert, Jose, Reyes, Adnolys, Valdes, Jose, Gonzalez, Maria C., Pedrayes, Jorge L., Avila, Melba, Herrera, Raiza, Infante, Mariela, Echevarria, Ernesto, Moreno, Myrna, Luaces, Patricia Lorenzo, Ramos, Tania Crombet
Publicat 2013